Mesothelioma Clinical Trials

One of the prominent areas of Malignant Mesothelioma research today is around the development of an effective, tolerable, second-line treatment for recurrent cases. Studies have shown mesothelioma recurrence is highly prevalent, even among patients who are able to undergo aggressive primary therapy, like surgery. Some studies have noted recurrence rates ranging from 10 – 72% of patients.

This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Malignant Mesothelioma development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. 

Malignant Mesothelioma Pipeline Therapeutics 2019

Pipeline Products covered across the following Developmental Stages:

• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Malignant Mesothelioma
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies, and patent details.

Pipeline Therapeutics assessment of products for Malignant Mesothelioma
The report assesses the active Malignant Mesothelioma pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis ’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

The scope of the report

• The report provides a snapshot of the pipeline development for the Malignant Mesothelioma.
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Malignant Mesothelioma.
• The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information.
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Malignant Mesothelioma.
• The report also covers the dormant and discontinued pipeline projects related to the Malignant Mesothelioma.

Reasons to Buy

• Establish a comprehensive understanding of the pipeline activity across this Malignant Mesothelioma to formulate effective R&D strategies.
• Gather information of the emerging competitors having a potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage.
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Malignant Mesothelioma therapeutics.
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress.

Malignant Mesothelioma Overview

Pipeline Therapeutics

• An Overview of Pipeline Products for Malignant Mesothelioma
Comparative Analysis, Products in Clinical Stage.

• Product Description
• Research and Development
• Product Development Activities
Products in Pre-Clinical and Discovery Stage
• Product Description
• Research and Development
• Product Development Activities
Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration 
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
Inactive Products

For more information, visit @ https://www.aarkstore.com/pharmaceuticals-healthcare/1052568/malignant-mesothelioma-pipeline-insight

Related Reports –

https://www.aarkstore.com/pharmaceuticals-healthcare/1052796/malignant-mesothelioma-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape

https://www.aarkstore.com/pharmaceuticals-healthcare/1053043/malignant-mesothelioma-epidemiology-forecast

https://www.aarkstore.com/pharmaceuticals-healthcare/1053389/malignant-mesothelioma-market-insight-epidemiology-and-market-forecast

Pregnancy and Ovulation – Is It a growing market in Asia-Pacific?

In the last two decades, many women are having their first child after the age of 35 – even age 40. Birth rates in women over the age of 35 are now the fastest growing, and the numbers of mothers aged 40-plus have nearly doubled in the last decade.

While this does somewhat dispel the dire warnings about later life fertility, older parents and parents-to-be are probably more likely to prepare for pregnancy with supplements, purchase ovulation kits to help plan conception, and potentially have more issues with fertility than younger first-time parents.

Pharmacies can support would-be parents of all age groups, but especially older couples, by providing a complete range of pharmacy services that cater for all stages of the journey, from pre-conception to birth and beyond.

What is Pregnancy Testing?

Pregnancy testing is the detection of human Chorionic Gonadotropin (hCG) in both urine and serum as early as seven to 10 days after conception, whereas, ovulation testing detects the Luteinizing Hormone (LH) level. The declining fertility rate, the emergence of highly accurate advanced technology, and the easy availability of ovulation and pregnancy monitors are expected to drive market growth. For instance, according to the statistics presented by the World Bank, India had a fertility rate of 3.311 in 2000 whereas in 2016 it declined to 2.326. However, the high costs associated with ovulation tests may hamper the growth of the market.

The demands and growth in Asia-Pacific

The Asia-Pacific pregnancy and ovulation testing market is expected to reach a market value of USD 298.68 million by 2023 from USD 209.37 million in 2017 and is expected to register a CAGR of 6.10% during the forecast period from 2018 to 2023. 

In 2017, the market was led by Japan with a 23.2% share, followed by China and India with shares of 22.5% and 19.7%, respectively. 

The growing demand for pregnancy testing has been observed in different parts of the world which fuels the growth of the market.

As a Market Leader in Asia-Pacific, what do you need to know?

Know the Asia-Pacific pregnancy and ovulation testing market by product type, mode of purchase, end user, and country.
Know pregnancy testing (hCG detection) and ovulation testing market.
Learn the Asia-Pacific pregnancy and ovulation testing market, by pregnancy testing (hCG detection), further segmented into urine-based testing and blood-based testing.
The Asia-Pacific pregnancy and ovulation testing market, by ovulation testing, is sub-segmented into ovulation prediction kits and fertility monitors.
The Asia-Pacific pregnancy and ovulation testing market, by mode of purchase, is segmented into non-prescription or OTC testing and prescription testing.
The Asia-Pacific pregnancy and ovulation testing market, by end user, is segmented into hospitals and clinics, fertility centers, and others.

Know your Key players:

SPD Swiss Precision Diagnostics GmbH

Fairhaven Health LLC

Church & Dwight Co. Inc.

Piramal Enterprises Ltd

Quidel Corporation

Mankind Pharma Ltd

TaiDoc Technology & Corporation

Cadila Healthcare Limited

Gregory Pharmaceutical Holdings Inc.

Statistics on the Market Trends:

The Asia-Pacific pregnancy and ovulation testing market is expected to reach USD 298.68 million by 2023 from USD 209.37 million in 2017 and is expected to register a CAGR of 6.10% during the forecast period from 2018 to 2023.
On the basis of product type, the pregnancy testing (hCG detection) segment is expected to account for the largest market share at a CAGR of 5.95% by 2023.
Based on mode of purchase, the non-prescription or OTC testing segment is expected to account for the largest market share at a CAGR of 6.0% by 2023.
Based on end user, the hospitals and clinics segment is expected to account for the largest market share at a CAGR of 5.78% by 2023.
Japan is expected to hold the largest share of the Asia-Pacific pregnancy and ovulation testing market at a CAGR of 23.2% by 2023.

To know more on Pregnancy and Ovulation Testing Market in Asia-Pacific, visit @ https://www.aarkstore.com/ict/1097438/global-residential-security-market-by-product-forecast-2023

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Glucose Tolerance Test Market surpasses validation.

What is a glucose tolerance test?

The glucose tolerance test generally measures the capability of the body cells for engrossing sugar or glucose soon after the patient consumes a certain amount of sugar. Specialists nowadays are making use of the haemoglobin A1C and fasting blood sugar level values for identifying the type 1 or type 2 diabetes. The glucose tolerance test is primarily used for diagnosing the gestational diabetes in the patients.

Global Glucose Tolerance Test Market Forecast until 2023

A glucose tolerance test measures how well your body’s cells are able to absorb glucose (sugar) after you consume a specific amount of sugar. Doctors use fasting blood sugar levels and hemoglobin A1c values to diagnose type 1 and type 2 diabetes as well as prediabetes. Doctors primarily use a glucose tolerance test to diagnose diabetes during pregnancy (called gestational diabetes).

Doctors often diagnose type 1 diabetes quickly because it usually develops rapidly and involves high blood sugar levels and symptoms. Type 2 diabetes, on the other hand, often develops over years. Type 2 diabetes is the most common form of diabetes, and it usually develops during adulthood.

Gestational diabetes occurs when a pregnant woman who hasn’t had diabetes before pregnancy has high blood sugar levels as a result of the pregnancy. The American Diabetes Association estimates that gestational diabetes occurs in up to 9.2 percent of pregnancies in the United States.

Who needs a glucose tolerance test?

Doctors should screen all pregnant women for gestational diabetes. Gestational diabetes can cause pregnancy complications, so early detection and prompt treatment are important.

Market demand

Growing prevalence and cases of diabetes mellitus is boosting the growth of the global glucose tolerance test market. However, the rising cost of treatment and diagnosis of diabetes could hamper the growth of the global glucose tolerance test in future. The global Glucose Tolerance Test market is expected to grow at a CAGR of 10.4% during the forecast period 2017-2023.

Market segmentation

The global Glucose Tolerance Test market is bifurcated on the basis of its products, end users, indications, and regional demand. On the basis of its products, the market is classified into Smart sensors, intramedullary Blood glucose testing kit (Lancet, Test strips, Meters, and others), and others. On the basis of its end users, the market is bifurcated into Hospitals, Diagnostic Clinics, Home, among others. Based on its indication, the global Glucose Tolerance Test market is segmented into Diabetes, Insulin resistance, Gestational diabetes, Reactive hypoglycemia. 

Major players

Some of the major industry players in the global Glucose Tolerance Test market include brands like Panasonic, F. Hoffman-La Roche Ltd, LifeScan, Inc Sanofi, Dexcom, Inc, Abbott Laboratories,Medtronic Plc among others.

To know more on Glucose Tolerance Test market, visit @ https://www.aarkstore.com/healthcare/1114320/glucose-tolerance-test-market-information-global-forecast-till-2023

Related Reports- 

 https://www.aarkstore.com/medical-devices/1114047/global-diabetes-devices-market-report-2019-history-present-and-future

https://www.aarkstore.com/healthcare/1114609/global-industrial-glucose-market-report-2019-history-present-and-future

https://www.aarkstore.com/pharmaceuticals-healthcare/768583/insulin-resistance-global-api-manufacturers-marketed-and-phase-iii-drugs-landscape-2018

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise

+91 7710006788 | contact@aarkstore.com | aarkstore.com

How Wearable Medical Devices are transforming Healthcare Industry

Wearable medical devices are autonomous, non-invasive devices that perform a specific medical function such as monitoring or support over a prolonged period of time. These devices are used in the treatment of various chronic illnesses such as asthma, diabetes, and heart disease. The main function of these devices is to collect information about the patient’s health condition. The growth of the global wearable medical device market can be attributed to technological advancements, an increasing number of smartphone-based healthcare apps compatible with wearable devices, and rising awareness about physical fitness.  

Global Wearable Medical Device Market 2023

As the wearable health technology market continues to grow it can be hard to distinguish the trendy consumer devices from those with useful medical applications. From the debate over smart watches to the latest wearable MRI scanner. Many of them are pointing the way to the future of patient care.

In the ever growing wearable health technology market, Fitbit is arguably the most well-known brand. Extremely popular with consumers, fitness tracking Fitbit watches are not a favorite among medical professionals due to claims that the patient data collected is not accurate enough for medical assertions to be made. However, Fitbit remains determined to break into the healthcare market and partnered with Google earlier this year to improve the ability of its devices to share data with medical professionals. The fitness wearable company has adopted Google Cloud for Healthcare application programming interfaces (APIs) in a bid to make data sharing more secure.

The more medically trusted smart watches include the FDA-approved Empatica smartwatch, called Embrace, which is designed to monitor seizures. The AI-powered device uses advanced machine learning to check for grand mal or generalised tonic-clonic seizures and can send instant alerts to caregivers.

These types of wearable scanners are so new that further research and development is needed before their future and relevance in the healthcare industry can be fully determined.

The global wearable medical device market is expected to reach a market value of USD 27,255.6 million by 2023 from USD 7,859.4 million in 2017 at a CAGR of 23.0% during the forecast period of 2018 to 2023.

In 2017, the Americas held the largest share of the market at 33.3%, followed by Europe and Asia-Pacific with shares of 27.2% and 24.4 %, respectively.

Market Segmentation

The global wearable medical device market has been segmented based on type, device type, application, distribution channel, and region.

By type, the global wearable medical device market has been classified as activity monitors, smart watches, smart clothing, and patches.
Based on device type, the global wearable medical device market has been categorized as diagnostic and monitoring devices and therapeutic devices. The diagnostic and monitoring devices segment has been further sub-segmented into vital sign monitoring devices, glucose monitoring devices, neuromonitoring devices, sleep monitoring devices, and fetal monitoring and obstetric devices. The therapeutic devices segment has been divided into pain management devices, rehabilitation devices, respiratory therapy devices, and insulin pumps.

The various application segments of the global wearable medical device market are sports academics and fitness, remote patient monitoring, and home healthcare.
By distribution channel, the global wearable medical device market has been segmented into hospitals and clinics, diagnostic centers, and ambulatory surgical centers.

Key Players: The key players in the global wearable medical device market are

Apple Inc. (US)
Fitbit Inc. (US)
Honeywell International Inc. (US)
Koninklijke Philips NV (Netherlands)
LG Electronics Inc. (South Korea)
NIKE Inc. (US)
Motorola Solutions Inc. (US)
Qualcomm Inc. (US)
Sony Corporation (Japan)
Omron Corporation (Japan)
Boston Scientific Corporation (US)
and Medtronic PLC (Ireland)

The Objective of the Study

• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global wearable medical device market.
• To provide insights into factors influencing and affecting market growth.
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries.
• To provide strategic profiling of key players in the market and comprehensively analyzing their market shares and core competencies, and drawing a competitive landscape for the market.
• To provide economic factors that influence the global wearable medical device market.
• To provide a detailed analysis of the value chain and supply chain of the global wearable medical device market.

Key Findings

• The global wearable medical device market is expected to reach USD 27,255.6 million by 2023 at a CAGR of 23.0 % from 2018 to 2023.
• On the basis of type, the activity monitors segment accounted for the largest market share at a CAGR of 22.4 % in 2017.
• The market in the Americas is expected to register a CAGR of 22.2% from 2018 to 2023.
• Asia-Pacific is expected to be the fastest-growing market registering a CAGR of 23.7% from 2018 to 2023.

To learn more on the industry, visit @ https://www.aarkstore.com/healthcare/1114325/global-wearable-medical-device-market-forecast-till-2023

Brain Hemorrhage Therapeutic

Brain Hemorrhage - Pipeline Insight Report 2019 

This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Brain Hemorrhage pipeline insights development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. 

Brain Hemorrhage Pipeline Insight 2019 

Pipeline Products covered across the following Developmental Stages:

• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Brain Hemorrhage

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies, and patent details.

Pipeline Therapeutics assessment of products for Brain Hemorrhage

The report assesses the active Brain Hemorrhage pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis ’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

The scope of the report

• The report provides a snapshot of the pipeline development for the Brain Hemorrhage.
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Brain Hemorrhage.
• The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information.
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Brain Hemorrhage.
• The report also covers the dormant and discontinued pipeline projects related to the Brain Hemorrhage.

Reasons to Buy

• Establish a comprehensive understanding of the pipeline activity across this Brain Hemorrhage to formulate effective R&D strategies.
• Gather information of the emerging competitors having the potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage.
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Brain Hemorrhage therapeutics.
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress.

For more information or for report request, visit @ https://www.aarkstore.com/pharmaceuticals-healthcare/1052408/brain-hemorrhage-pipeline-insight

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Cataract Drugs under Development

Cataract Pipeline Insight, 2019

This report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cataract development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. 

Cataract Pipeline Insight 2019

Pipeline Products covered across the following Developmental Stages:

• Clinical
• Non-clinical
• Inactive: Discontinued and/or Dormant

Descriptive coverage of pipeline development activities for Cataract

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies, and patent details.

Pipeline Therapeutics assessment of products for Cataract

The report assesses the active Cataract pipeline products by developmental stage, product type, molecule type, and administration route.

Methodology

Data used in the report are sourced primarily from internal databases, primary and secondary research and in-house analysis ’s team of industry experts.
Information and data from the secondary sources have been obtained from various printable and non-printable sources like search engines, news websites, global regulatory authorities websites, trade journals, white papers, magazines, books, trade associations, industry associations, industry portals and access to available databases.

The scope of the report

• The report provides a snapshot of the pipeline development for the Cataract.
• The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Cataract.
• The report provides pipeline product profiles which include product description, developmental activities, licensors & collaborators and chemical information.
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Cataract.
• The report also covers the dormant and discontinued pipeline projects related to the Cataract.

Reasons to Buy

• Establish a comprehensive understanding of the pipeline activity across this Cataract to formulate effective R&D strategies.
• Gather information of the emerging competitors having a potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage.
• Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
• Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Cataract therapeutics.
• Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress.

For more information or for report request, visit @ https://www.aarkstore.com/pharmaceuticals-healthcare/1052417/cataract-pipeline-insight

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Telemedicine Industry Developments

Global Telemedicine Market Research Report, By Service Type (Telenursing), Component (Software, Hardware), Deployment (Cloud-Based, On-Premises), Application (Cardiology, Radiology, Dermatology) End Users (Hospitals, Clinics) - Global Forecast Till 2023
 

Global Telemedicine Market Report 2023

The telemedicine fills in as an arrangement for different remote clinical administrations, which bring about with the assistance of ongoing, two-route correspondence between the patient and the healthcare center. This includes the utilization of an assortment of electronic, sound, and visual methods. An expanding selection of electronic healthcare record (EHR) or the electronic medical record (EMR) is a noteworthy driver for market development amid the estimate time period. 

Furthermore, the growing occurrence of chronic diseases like cancer, diabetes, besides others and the lack of good physicians and good health care services in few regions is boosting the demand of the global telemedicine market. This type of e-hospital facility gives online client benefit from the teleconsulting process to global transfer and treatment.

Nonetheless, the surprising expense of executing telemedicine frameworks, i.e., EMR and EHR and requirement for telemedicine training pursued by stringent government directions relating to telemedicine are evaluated to hamper the market development amid the forecast period.

Market Segmentation

The global telemedicine market is divided on the basis of its service type, deployment, component, application, end user and regional demand. Based on its service type, the market is segmented into telepharmacy, telenursing, teleradiology, tele-oncology, teledermatology, others.

On the basis of the component, the global market is sectioned into hardware and software. Based on its deployment, the market is classified into on premises and cloud-based.

On the basis of its application, the global telemedicine market is segmented into ophthalmology, cardiology, psychiatry, dermatology, radiology, and others. Based on its end user, the market is bifurcated into clinics, hospitals, and home care. 

Regional Analysis

The global telemedicine market has been spanned across global regions like Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa.

Key Players

The industry players for the global telemedicine market include companies like AMD Global Telemedicine, Inc., CareClix, CardioNet, Cerner Corporation, GENERAL ELECTRIC, Cisco, IBM Corporation, Iris Telehealth, Intel Corporation, Koninklijke Philips N.V., TeleVital, Aerotel Medical Systems, Medtronic, SHL Telemedicine, Allscripts Healthcare Solutions, Honeywell Lifesciences, Cardiocom, Tunstall Healthcare, Medvivo Group Ltd., Care Innovations, Aerotel Medical Systems Ltd., among others.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/1020525/global-telemedicine-market-research-report-by-service-type-component-deployment-application-end-users-global-forecast

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

global radiology information systems market

A radiology information system (RIS) is a core system used to manage medical images and associated data. The radiology information system has the ability to handle a massive amount of data in the form of images, demographics, clinical information, patient history, billing, and scheduling in one system thereby allowing efficient workflow management and rapid communication among healthcare professionals. The increasing spending on the healthcare IT sector, increasing applications of RIS, the rising prevalence of chronic diseases, and growing elderly population are expected to drive market growth.

radiology information systems market

According to the United States Census Bureau, around 49.2 million adults aged 65 and above were present in the US as of 2016. Moreover, the National Cancer Institute in 2016 reported that an estimated 595,690 people died from cancer and 1,685,210 new cases of the disease were diagnosed in the US. However, the lack of skilled radiology professionals, security concerns, and the high cost of software may hamper the growth of the market.

The global radiology information systems market is expected to reach a market value of USD 1,111.1 million by 2023 from USD 640.0 million in 2016 and is expected to register a CAGR of 8.20% during the forecast period from 2018 to 2023. In 2016, the Americas held the highest share of the market at 40.3%, followed by Europe and Asia-Pacific with shares of 34.5% and 17.5%, respectively. The increasing applications of radiology information systems are expected to increase the growth of the market during the forecast period.

The global radiology information systems market is segmented into type, component, deployment, end user, and region.

The global radiology information systems market, by type, is segmented into an integrated radiology information system and standalone radiology information system.
The global radiology information systems market, by component, is segmented into software, services, and hardware.
The global radiology information systems market, by deployment, is segmented into cloud-based/web-based and on-premise.
By end user, the global radiology information systems market is segmented into hospitals and clinics, research and academic institutes, and others.
The global radiology information systems market is expected to have a value of USD 1,111.1 million by 2023 from USD 692.5 million in 2017 and is expected to register a CAGR of 8.20% during the forecast period from 2018 to 2023.

Key Players

Carestream Health, Epic Systems, eRAD, Cerner Corporation, Bayer AG, Koninklijke Philips N.V., GE Healthcare, Image Information Systems, Ambra Health, Advanced Data Systems Corporation, Perfect Imaging LLC, IBM Watson Health, Allscripts Healthcare Solutions, Medinformatix, Inc, and NextGen Healthcare

Study Objectives

• To provide a detailed analysis of the market structure along with the forecast of various Segments and sub-Segments of the radiology information systems market.
• To provide insights into factors affecting the market growth.
• To analyze the global radiology information systems market based on various tools such as supply chain analysis and Porter’s five force analysis.
• To provide historical and forecast revenue of market Segments and sub-Segments with respect to regions and their respective key countries.
• To provide country-level analysis of the market with respect to the current market size and future perspective.
• To provide country-level analysis of the market for Segments by type, component, deployment, end user, and region.
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the radiology information systems market.

Key Findings

• The global radiology information systems market is expected to reach USD 1,111.1 million by 2023 at a CAGR of 8.20 % from 2018 to 2023.
• On the basis of type, the integrated radiology information systems segment is expected to account for the largest market share at a CAGR of 8.59% by 2023.
• On the basis of the component, the software segment is expected to account for the largest market share at a CAGR of 8.66% by 2023.
• On the basis of deployment, the cloud-based/web-based segment is expected to account for the largest market share at a CAGR of 8.64% by 2023.
• On the basis of end user, the hospitals and clinics segment is expected to account for the largest market share at a CAGR of 7.85% by 2023.
• The Americas is expected to hold the largest share of the global radiology information systems market at a CAGR of 8.45% by 2023.
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 8.66% by 2023.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/1063667/radiology-information-system-market-global-forecast

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com

Home healthcare market in India

The Home Healthcare Market Research Report offers Market Analysis by Product (Therapeutic products, Other), Service (Skilled Nursing Services, Respiratory Therapy Service, Other), Software (Clinical Management System, Telehealth Solution, Other), Global Forecast Till 2023.

Market Analysis

Home healthcare is an expanding practical choice being favored by patients inferable from increasing healthcare costs and the thriving geriatric populace. Home healthcare services provide one with different services including physical therapy, occupational therapy, speech therapy, and skilled nursing. The digitization of information has made it less complex for the patients to contact doctors and physicians and gain a precise diagnosis from their home. The global home healthcare market is expected to grow at a CAGR of 8.1% during the forecast period 2017 to 2023.

Global Home Healthcare Market 2023

Various technical and scientific advances in healthcare and other diagnosis devices along with several other government initiatives are encouraging the home healthcare system to fuel the market demand in the upcoming years. This type of home healthcare system has made it very easier for the senior or aged and bedridden patients to get in touch with their physicians and recuperate normally.

Market Segmentation

The global home healthcare market is divided on the basis of its product, software, service, and regional demand. Based on its product, the market is segmented into the screening, therapeutic and testing, and monitoring products. On the basis of its software, the global market is bifurcated into agency software, telehealth solution, hospice solutions, and clinical management systems. Based on its services, the market is classified into unskilled care services, skilled nursing services, respiratory therapy services, infusion therapy services, rehabilitation therapy services, and pregnancy care services.

Regional Analysis

The global home healthcare market is divided into four major global regions including Europe, Asia Pacific (APAC), North America, and the Middle East and Africa (MEA).

Major Players

The major players in the home healthcare market include brands like Koninklijke Philips N.V. (The Netherlands), A&D Company (Japan), F. Hoffmann-La Roche AG (Switzerland), Fresenius SE & Co KGaA (Germany), GE Healthcare (U.S.), Abbott (U.S.), McKesson Corporation (U.S.), Becton Dickinson Company (U.S.), B. Braun Melsungen AG (Germany), Omron Corporation (Japan), LG Electronics (South Korea), Medtronic PLC (U.S.), Kinnser Software (U.S.), 3M (U.S.), Apple (U.S.), and others.

For more information or for report request, visit @ https://www.aarkstore.com/healthcare/1038995/global-home-healthcare-market-research-report-forecast-till-2023

About Aarkstore Enterprise:

Aarkstore Enterprise is one among global marketing research companies dealing in the resale of market reports across different industries and countries. Serving thousands of clients annually with syndicated, custom market research and consulting. Clients from all sectors, including public, private, and commercial are endowed with best data modeling and processing structures with custom reports.

Related Reports: Healthcare Market Reports

Contact Details:

Aarkstore Enterprise
+91 7710006788 | contact@aarkstore.com | aarkstore.com